Mechanism od Cardiac Hypertrophy ; The Efficacy of Gene Therapy in Cardiac Hypertrophy
Mechanism od Cardiac Hypertrophy ; The Efficacy of Gene Therapy in Cardiac Hypertrophy
批准号:
08457350
负责人:
TAKAHASHI Toshiki
金额:
$4.03万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
心肌肥大是心脏对机械负荷增加的一种基本适应机制。心力衰竭是心血管疾病的最终表现,如冠状动脉疾病、高血压、瓣膜心脏病、心肌炎等。转变为心功能不全和心力衰竭的致病机制还不是很清楚。通过腹主动脉和下腔静脉之间的动静脉分流术建立容量超负荷大鼠心脏模型。免疫组织化学方法检测原癌基因蛋白的表达。A=V分流后第14天,容量超负荷组心肌细胞直径明显大于对照组。容量超负荷的心脏重量也明显大于对照心脏。在容量超负荷心肌细胞核内,Fos和Myc蛋白在房室分流术后第2天达到高峰。第2天以后,表达逐渐减弱。然而,在人类心脏中,这些原癌基因是否与心肌收缩损伤和结构改变有关尚不清楚。本研究旨在探讨慢性主动脉瓣反流患者心肌C-Myc蛋白表达与心肌收缩功能障碍的关系。12例患者中有9例检测到c-Myc,而正常对照组均未检测到c-Myc。C-Myc表达程度与EF、ESS/ESVI呈显著正相关,与ESVI、CD、FC呈显著负相关,提示C-Myc表达程度可能与心肌收缩功能、心肌肥厚程度呈显著负相关。结论:C-Myc的表达可能与慢性主动脉瓣关闭不全患者心肌重构的发生有关。
英文摘要
Myocardial hypertrophy is a basic adaptive mechanism of the heart to compensate for an increased mechanical load. Heart failure is final presentation of cardiovascular disease, such as coronary artery disease, hypertension, valvular heart disease, myocarditis and others. The pathogenetic mechanisms responsible for the transition to cardiac dysfunction and heart failure are not well understood. Volume-overloaded rat hearts were established by A-V shunt between abdominal aorta and inferior caval vein. Immunohistochemical investigations of proto-oncogene proteins were performed in the presence. The myocytes of volume-overloaded hearts were significantly larger in diameter than control hearts on 14th day after A=V shunt. The weight of volume-overloaded hearts was also significantly larger than control hearts. In nuclei of myocytes of volume-overloaded hearts, the maximum expression of Fos and Myc protein was observed on the 2nd day after A-V shunt. After the 2nd day, the expression decreased gradually. In the human heart, however, it has not been clarified whether these proto-oncogenes are related to contractile impairment and structural alteration of the myocardium. The present study is designed to investigate the relationship between the C-Myc protein expression in the myocardium and the myocardial contractile dysfunction in patients with chronic aortic regurgitation. C-Myc was detected in nine of 12 present patients but in none of the normal controls. The degree of C-Myc expression had significant positive correlations with EF and ESS/ESVI and significant negative correlations with ESVI,CD and FC,which suggested that the degree of C-Myc expression may have a significant negative correlation with myocardial contractility and myocardial hypertrophy. Conclusion : C-Myc expression may be related to the pathogenesis of myocardial remodeling in patients with chronic aortic regurgitation.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Satoshi Taketani: "C-Myc expression and its role in patients with chronic aortic regurgitation" Circulation. 96. II83-II89 (1997)
Satoshi Taketani:“C-Myc 表达及其在慢性主动脉瓣反流患者中的作用”循环。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
竹谷哲: "容量負荷による心筋細胞肥大の発生機序の検討-癌遺伝子とPKCの関与-" 心筋の構造と代謝. 18. 223-227 (1996)
Satoshi Takeya:“容量负荷引起的心肌细胞肥大机制的检查 - 癌基因和 PKC 的参与”《心肌结构与代谢》18. 223-227 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Taketani, Y.Sawa, K.Kadoba, S.Ohtake, K.Kagisaki, N.Kawaguchi, S.Onishi, H.Matsuda: "DNA Damage may be a Mechanism of Heart Failure in the Volume Overloaded Rat Heart." Cardiac Structure and Metabolism.19. 331-334 (1997)
S.Taketani、Y.Sawa、K.Kadoba、S.Ohtake、K.Kagisaki、N.Kawaguchi、S.Onishi、H.Matsuda:“DNA 损伤可能是容量超载的大鼠心脏中心力衰竭的机制。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Taketani, Y.Sawa, K.Kadoba, K.Taniguchi, H.Matsuda, N.Kawaguchi, S.Ohnishi: "Effect of Proto-oncogene and Protein Kinase C in Volume-Overloaded Rat Heart." Step of Medical Science.180 (10). 662-663 (1997)
S.Taketani、Y.Sawa、K.Kadoba、K.Taniguchi、H.Matsuda、N.Kawaguchi、S.Ohnishi:“原癌基因和蛋白激酶 C 对容量超载的大鼠心脏的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
竹谷 哲: "容量負荷肥大心における心不全発生へのDNA障害の関与" 医学のあゆみ. 180-10. 662-663 (1997)
Satoshi Takeya:“容量负荷肥大心脏中 DNA 损伤的发生”,《医学史》180-10 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
Neutralization process of an accelerated compact torus plasma for deep fuelling into a fusion plasma
-
批准号:21760687
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$1.58万
-
财政年份:2009
-
负责人:TAKAHASHI Toshiki
-
依托单位:
Myocardial angiogenesis treatment for ungraftable ischemic heart disease : Efficacy of intramural injection of human recombinant hepatocyte growth factor in conjunction with transmyocardial laser revascularization
-
批准号:10671255
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1998
-
负责人:TAKAHASHI Toshiki
-
依托单位:
海外基金